600211.SS
Tibet Rhodiola Pharmaceutical Holding Co
Price:  
36.35 
CNY
Volume:  
2,846,247.00
China | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

600211.SS Probability of Bankruptcy

The Probability of Bankruptcy of Tibet Rhodiola Pharmaceutical Holding Co (600211.SS) is -% . This number represents the probability that 600211.SS will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating 600211.SS's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

600211.SS - ESG ratings

ESG ratings are directly linked to the cost of capital and 600211.SS's ability to raise funding, both of which can significantly affect the probability of Tibet Rhodiola Pharmaceutical Holding Co going bankrupt.

ESG Score -
Environment Score -
Social Score -
Governance Score -
Returns
Historical Returns (5 day) 1.88%
Historical Returns (MTD) 2.39%
Historical Returns (YTD) -1.60%
Historical Returns (13 week) -0.11%
Historical Returns (26 week) -3.96%
Historical Returns (52 week) 21.34%
Efficiency
Asset Turnover 0.57
Receiveable Turnover 4.77
Gross Margin 92.88%
Operating Margin 39.64%
Pretax Margin 39.31%
Net Margin 35.80%
Return on Asset (ROA) 21.19
Return on Equity (ROE) 28.04
Return on Investments (ROI) 24.29
Price Metrics
Market Cap (M) 11,716.33
Enterprise Value (M)
52 Week High 45.12
52 Week Low 31.23
Beta 1.17
Average Volume (10 day) 2.83
Average Volume (3 month) 3.57
Price / Earnings (P/E) 11.50
Price / Sales (P/S) 4.12
Earnings
EPS 3.12
Revenue CAGR (5 year) 17.45%
Risk
Current Ratio 4.66
Quick Ratio 4.47